| |
|
|
|
Cytosorbents Cor  
|
|
9.62 0.04 (0%) |
01-25 16:00 |
|
Open: |
9.57 |
Pre close: |
9.58 |
Target:
|
11.33 
|
|
High: |
9.7 |
Low: |
9.28 |
Resistance:
|
9.70
11.33
|
|
Volume: |
270,751 |
Market Cap: |
415M |
Support:
|
8.59
7.91
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.30
|
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
8.72 |
Signal(12,26,9): |
0.16 |
|
MA(100): |
8.38 |
Stochastic Oscillator |
%K(14,3):
|
94.48 |
|
MA(250): |
8.25 |
%D(3): |
87.76 |
|
Average Volume(K) |
3-Month: |
29396
|
52-Week |
High:
|
11.74 |
|
10-Days: |
40816 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
65.33 |
Change(%): |
104.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.310 |
Return on Equity (ttm) |
-25.5 |
Shares Out. (M) |
43.18 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-12.4 |
Shares Float (M) |
39.56 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.39 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
73.0 |
% Held by Institutions |
40.73 |
|
Forward EPS |
-0.600 |
Gross Profit (p.s.) |
0.407 |
Shares Short (K) |
3100 |
|
Book Value (p.s.) |
1.860 |
EBITDA (p.s.) |
-0.289 |
P/E |
-31.03 |
|
Sales Per Share |
0.845 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.17 |
|
Profit Margin |
-30.45 |
Operating Cash Flow
(M) |
-8.68 |
P/S |
11.39 |
|
Operating Margin |
-36.10 |
Levered Free Cash Flow
(M) |
-7.07 |
P/CF |
-47.86 |
|
|
|
|
|
|
